We carried out a further study of the long-term results of the
cemented Exeter femoral component in patients under the age of 40
with a mean follow-up of 13.6 years (10 to 20). We reviewed our original cohort of 104 cemented Exeter stems
in 78 consecutive patients with a mean age of 31 years (16 to 39).
Only one patient was lost to radiological follow-up.Aims
Patients and Methods
We evaluated the outcome of 104 consecutive primary cemented Exeter femoral components in 78 patients (34 men, 44 women) under the age of 40 years who underwent total hip replacement between October 1993 and May 2004. The mean age at operation was 31 years (16 to 39). No hip was lost to follow-up, but three patients (four hips) died. None of the deaths were related to the surgery. At a mean follow-up of 6.2 years (2 to 13), three femoral components had been revised for septic loosening. Using Kaplan-Meier survival analysis, the seven-year survival of the component with revision for any reason as the endpoint was 95.8% (95% confidence interval 86.67 to 98.7). The seven-year survival with aseptic femoral loosening as the endpoint was 100% (95% confidence interval 100). The cemented Exeter femoral component in patients under the age of 40 shows promising medium-term results. As it is available in a wide range of sizes and offsets, we could address all types of anatomical variation in this series without the need for custom-made components.
Patients were assessed clinically by the junior author (CW) and results were standardised using the Hospital for Specialist Surgery (HSS) knee score. Complications were quantified from patient history and examination of the case notes. Results: Results: Two hundred and two knees were reviewed. The results were then consolidated into groups with a minimum follow up of 2,3,4 and 5 years. The average HSS score was consistent at 91 for all four groups. Complications were also consistent ranging between 10 and 11% in all groups. These are summarised in Tables 1–4 below. The commonest complication was superficial wound infection (4.95%). There were also three deep infections (1.49%) and two revisions due to meniscal failure (0.99%). These results suggest the Rotaglide total knee Arthroplasty offers safe and effective treatment for osteoarthritis with constantly good clinical results at 2–5 years follow up. The complication rate was also consistent over this period with a low incidence of meniscal failure and deep infection. There have been no failures due to aseptic loosening in this group to date.